Collaborative programs

The ICM is part of a national, European and international network, bringing together the major research centers in order to meet the scientific research missions.
Open / close summary

At the International level

At the International level, the main partners are the Sandler Neuroscience Center (UCSF, San Francisco, USA), the Montreal Neurological Institute and Hospital (Mc Gill University, Montreal, Canada) or the Florey Institute (Melbourne, Australia).


  • Six genetic risk factors for Parkinson’s disease have been discovered thanks to a study conducted by an international consortium of researchers, including Professor Alexis Brice’s team at the Brain and Spine Institute. The discovery of these new genetic risk factors is the result of a long and complex study that began in 2010 and has relied on the cooperation and pooling of resources across several international public and private institutions, including the US National Institute of Health (NIH), the US Department of Defense and the Michael J. Fox Foundation. The results were published on the 27th of July 2014 in the prestigious journal, Nature Genetics.
  • Dr. Claire Wyart is leading a research team working on the spinal cord nerve networks at the Brain and Spine Institute – Institut du Cerveau – ICM – in Paris. In team with Dr. Patrick Delmas, CNRS Research Director at the Center for Neurobiology and Neurophysiology in Marseille, and Dr. Katharine Lewis, Associate Professor of Biology at the College of Arts and Sciences, Syracuse University, New York, Dr. Wyart is the lucky recipient and principal coordinator of one of the 24 HFSP 2014 grants, awarded by the international organization HFSP – Human Frontier Science Program.
  • As part of strengthening international exchanges between France and Canada, the Brain and Spine Institute – Institut du Cerveau – ICM – will host a newcomer in his incubator IPEPS-Institut du Cerveau – ICM: Company NeoVentures Biotechnology Inc. (London, Ontario). This collaboration has been under the CTA program for Canadian Technology Accelerator – The Canadian Technology Accelerator.

To build and grow the best research teams, the Institut du Cerveau – ICM formed an international Scientific Advisory Board to identify and recruit top talent. Its rigorous selection process is one of the main factors ensuring the Institut du Cerveau – ICM’s scientific excellence.

At the European level

At the European level, the main partners are the Institute of Neurology (UCL, London, United Kingdom) and the German Center of Neurodegenerative diseases-DZNE (Helmholtz, Germany).

Example: MoU signed with Deutches Zentrum für Neurodegenerative Erkrankungen (DZNE), Helmoltz – Bonn and Institute of Neurology (IoN) – Londres

At the national level

At the national level, the Institut du Cerveau – ICM works in close relationship with the Sorbonne Université through the IHU-A-Institut du Cerveau – ICM. The Institut du Cerveau – ICM is part of Neuropôle et the École des Neurosciences de Paris (ENP), in network with the other major Parisian research centers: Ecole Normale Supérieure, Institute of Vision, MIRCen, Neurospin, Pasteur Institute…

Research at the MHI developed in cooperation with major French neuroscience centers including: the main partners are:

  • Bordeaux, neurophysiology
  • Caen, neuroimaging
  • Grenoble, engineering sciences, neurobiology
  • Lille, neuropathology
  • Lyon, neurophysiology, neuroimaging
  • Marseille, neurophysiology, neuroimaging
  • Montpellier, neurogenetics, neurobiology
  • Strasbourg, neurobiology, neurogenetics
  • Toulouse, genetics, neuroimaging

Example: The Cyceron center of Caen and Institut du Cerveau – ICM signed a partnership agreement to develop scientific collaborations. Indeed, teams of researchers working on neurodegenerative diseases such as Alzheimer’s disease have decided to work together on a first scientific research project on frontotemporal diseases.